Linked Data API

Show Search Form

Search Results

1144589
registered interest false more like this
date less than 2019-09-04more like thismore than 2019-09-04
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Medical Treatments remove filter
house id 1 remove filter
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, whether his Department has undertaken a public consultation on the effectiveness of the NHS prioritisation process. more like this
tabling member constituency Strangford more like this
tabling member printed
Jim Shannon more like this
uin 286740 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-09-09more like thismore than 2019-09-09
answer text <p>It has not proved possible to respond to the hon. Member in the time available before Prorogation.</p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
question first answered
less than 2019-09-09T16:35:45.897Zmore like thismore than 2019-09-09T16:35:45.897Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
4131
label Biography information for Jim Shannon more like this
1142688
registered interest false more like this
date less than 2019-09-02more like thismore than 2019-09-02
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Medical Treatments remove filter
house id 1 remove filter
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps his Department is taking to make the stabilisation of conditions such as cystic fibrosis part of the NICE quality of life measurement system and not just extension of life. more like this
tabling member constituency Bermondsey and Old Southwark more like this
tabling member printed
Neil Coyle more like this
uin 284175 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-09-09more like thismore than 2019-09-09
answer text <p>It has not proved possible to respond to the hon. Member in the time available before Prorogation.</p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
question first answered
less than 2019-09-09T17:27:04.567Zmore like thismore than 2019-09-09T17:27:04.567Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
4368
label Biography information for Neil Coyle more like this
1142692
registered interest false more like this
date less than 2019-09-02more like thismore than 2019-09-02
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Medical Treatments remove filter
house id 1 remove filter
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 2 April 2019 to Question 236381, what steps NHS England has taken to fill the gap left by the closure of the Commissioning Support Programme for treatments that are awaiting review by the Clinical Priorities Advisory Group. more like this
tabling member constituency Strangford more like this
tabling member printed
Jim Shannon more like this
uin 284181 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-09-09more like thismore than 2019-09-09
answer text <p>Further to the answer the Minister of State for Care (Caroline Dinenage MP) gave on 2 April 2019 to Question 236381, that NHS England has considered this issue, and does not believe that a gap has been created as a result of the closure of Commissioning Support Programme for treatments that are awaiting review by the Clinical Priorities Advisory Group.</p><p>The topics that would have been referred to the Commissioning Support Programme will now be routed to the appropriate appraisal programme.</p><p>All policy propositions relating to topics previously being supported in development through the Commissioning Support Programme have been handed over at the agreed stage for post stakeholder testing. These are now being progressed though the usual development process. Further information is available at the following link:</p><p><a href="https://www.england.nhs.uk/publication/methods-national-clinical-policies/" target="_blank">https://www.england.nhs.uk/publication/methods-national-clinical-policies/</a></p><p> </p><p> </p><p> </p>
answering member constituency Kingswood more like this
answering member printed Chris Skidmore more like this
grouped question UIN 284182 more like this
question first answered
less than 2019-09-09T18:52:46.33Zmore like thismore than 2019-09-09T18:52:46.33Z
answering member
4021
label Biography information for Chris Skidmore more like this
tabling member
4131
label Biography information for Jim Shannon more like this
1142693
registered interest false more like this
date less than 2019-09-02more like thismore than 2019-09-02
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Medical Treatments remove filter
house id 1 remove filter
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect on treatments within NHS England’s Clinical Commissioning Policy programme of the closure of the Commissioning Support Programme; and if he will make a statement. more like this
tabling member constituency Strangford more like this
tabling member printed
Jim Shannon more like this
uin 284182 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-09-09more like thismore than 2019-09-09
answer text <p>Further to the answer the Minister of State for Care (Caroline Dinenage MP) gave on 2 April 2019 to Question 236381, that NHS England has considered this issue, and does not believe that a gap has been created as a result of the closure of Commissioning Support Programme for treatments that are awaiting review by the Clinical Priorities Advisory Group.</p><p>The topics that would have been referred to the Commissioning Support Programme will now be routed to the appropriate appraisal programme.</p><p>All policy propositions relating to topics previously being supported in development through the Commissioning Support Programme have been handed over at the agreed stage for post stakeholder testing. These are now being progressed though the usual development process. Further information is available at the following link:</p><p><a href="https://www.england.nhs.uk/publication/methods-national-clinical-policies/" target="_blank">https://www.england.nhs.uk/publication/methods-national-clinical-policies/</a></p><p> </p><p> </p><p> </p>
answering member constituency Kingswood more like this
answering member printed Chris Skidmore more like this
grouped question UIN 284181 more like this
question first answered
less than 2019-09-09T18:52:46.377Zmore like thismore than 2019-09-09T18:52:46.377Z
answering member
4021
label Biography information for Chris Skidmore more like this
tabling member
4131
label Biography information for Jim Shannon more like this
1142749
registered interest false more like this
date less than 2019-09-02more like thismore than 2019-09-02
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Medical Treatments remove filter
house id 1 remove filter
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what the budget is for products undergoing review via the NHS England prioritisation process in 2020-21. more like this
tabling member constituency Strangford more like this
tabling member printed
Jim Shannon more like this
uin 284324 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-09-09more like thismore than 2019-09-09
answer text <p>NHS England has not yet been set the budget for products undergoing review via the NHS England prioritisation process in 2020-21.</p> more like this
answering member constituency Kingswood more like this
answering member printed Chris Skidmore more like this
question first answered
less than 2019-09-09T18:37:16.187Zmore like thismore than 2019-09-09T18:37:16.187Z
answering member
4021
label Biography information for Chris Skidmore more like this
tabling member
4131
label Biography information for Jim Shannon more like this
1143648
registered interest false more like this
date less than 2019-09-02more like thismore than 2019-09-02
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Medical Treatments remove filter
house id 1 remove filter
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the potential effect on the supply chains for medicines and medical supplies of the UK leaving the EU without a deal; what steps he is taking to protect ongoing supplies of medicines and medical supplies; and if he will update the dear colleague letter of the 27 June 2019 entitled No deal Brexit contingency planning assumptions for continuity of supply of medicines and medical products. more like this
tabling member constituency Eddisbury more like this
tabling member printed
Antoinette Sandbach more like this
uin 285138 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-09-05more like thismore than 2019-09-05
answer text <p>As part of a responsible Government, the Department is doing everything appropriate to prepare for European Union exit. We want to reassure patients that we should be fully prepared for leaving on 31 October, and that our plans should ensure the supply of medicines and medical products remains uninterrupted when we leave the EU.</p><p>The Department is implementing a multi-layered approach, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. This should ensure the continuity of supply of medicines and medical products following EU exit.</p><p>We continue to engage with stakeholders and update our communications regularly. We are looking to update Members shortly.</p> more like this
answering member constituency Kingswood more like this
answering member printed Chris Skidmore more like this
question first answered
less than 2019-09-05T16:37:54.86Zmore like thismore than 2019-09-05T16:37:54.86Z
answering member
4021
label Biography information for Chris Skidmore more like this
tabling member
4506
label Biography information for Antoinette Sandbach more like this
1143719
registered interest false more like this
date less than 2019-09-02more like thismore than 2019-09-02
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Medical Treatments remove filter
house id 1 remove filter
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what plans the Government has to maintain medical and drug supplies to the UK in the event that the UK leaves the EU without a deal. more like this
tabling member constituency Lanark and Hamilton East more like this
tabling member printed
Angela Crawley more like this
uin 285347 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-09-09more like thismore than 2019-09-09
answer text <p>As part of a responsible Government, the Department is doing everything appropriate to prepare for European Union exit. We want to reassure patients that our plans should ensure the supply of medicines and medical products remains uninterrupted when we leave the EU on 31 October.</p><p>The Department is implementing a multi-layered approach, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages.</p> more like this
answering member constituency Kingswood more like this
answering member printed Chris Skidmore more like this
question first answered
less than 2019-09-09T19:00:53.243Zmore like thismore than 2019-09-09T19:00:53.243Z
answering member
4021
label Biography information for Chris Skidmore more like this
tabling member
4469
label Biography information for Angela Crawley more like this